Variant report

Variant	nsv970100
Chromosome Location	chr6:29601673-29604881
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:75)
CpG islands
(count:367)
Chromatin interactive
region (count:4)
LncRNA
region (count:1)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:75 , 50 per page) page: 1 2

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	BATF	chr6:29603750-29603925	GM12878	blood:	n/a	n/a
2	CEBPB	chr6:29603146-29603217	HepG2	liver:	n/a	chr6:29603197-29603208 chr6:29603197-29603210
3	CEBPB	chr6:29603114-29603364	K562	blood:	n/a	chr6:29603197-29603208 chr6:29603197-29603210
4	CHD2	chr6:29602586-29602614	GM12878	blood:	n/a	n/a
5	EGR1	chr6:29604105-29604262	GM12878	blood:	n/a	n/a
6	FOS	chr6:29602515-29602612	MCF10A-Er-Src	breast:	n/a	n/a
7	GTF2F1	chr6:29601687-29601739	H1-hESC	embryonic stem cell:	n/a	n/a
8	HEY1	chr6:29604002-29604278	HepG2	liver:	n/a	n/a
9	HEY1	chr6:29604002-29604246	HepG2	liver:	n/a	n/a
10	HEY1	chr6:29604049-29604264	K562	blood:	n/a	n/a
11	HEY1	chr6:29604005-29604277	K562	blood:	n/a	n/a
12	JUND	chr6:29600153-29601852	K562	blood:	n/a	n/a
13	MAZ	chr6:29598835-29601887	K562	blood:	n/a	chr6:29600301-29600311 chr6:29601521-29601531
14	MAZ	chr6:29599759-29601808	IMR90	lung:	n/a	chr6:29600301-29600311 chr6:29601521-29601531
15	POLR2A	chr6:29604057-29604247	H1-hESC	embryonic stem cell:	n/a	n/a
16	POLR2A	chr6:29599885-29601775	H1-neurons	neurons:	n/a	n/a
17	POLR2A	chr6:29604077-29604240	A549	lung:	n/a	n/a
18	POLR2A	chr6:29604004-29604254	H1-hESC	embryonic stem cell:	n/a	n/a
19	POLR2A	chr6:29604116-29604464	H1-hESC	embryonic stem cell:	n/a	n/a
20	POLR2A	chr6:29603842-29604303	GM12892	blood:	n/a	n/a
21	POLR2A	chr6:29603918-29604322	Hela-S3	cervix:	n/a	n/a
22	POLR2A	chr6:29604080-29604234	HepG2	liver:	n/a	n/a
23	POLR2A	chr6:29604007-29604248	GM12878	blood:	n/a	n/a
24	POLR2A	chr6:29604053-29604242	HepG2	liver:	n/a	n/a
25	POLR2A	chr6:29603994-29604372	H1-hESC	embryonic stem cell:	n/a	n/a
26	POLR2A	chr6:29603953-29604403	SK-N-MC	brain:	n/a	n/a
27	POLR2A	chr6:29603986-29604286	GM12891	blood:	n/a	n/a
28	POLR2A	chr6:29603713-29604342	H1-hESC	embryonic stem cell:	n/a	n/a
29	POLR2A	chr6:29604120-29604381	MCF-7	breast:	n/a	n/a
30	POLR2A	chr6:29599663-29601899	SK-N-MC	brain:	n/a	n/a
31	POLR2A	chr6:29604072-29604225	A549	lung:	n/a	n/a
32	POLR2A	chr6:29602610-29602631	ProgFib	skin:	n/a	n/a
33	POLR2A	chr6:29604087-29604248	A549	lung:	n/a	n/a
34	POLR2A	chr6:29604003-29604271	GM12891	blood:	n/a	n/a
35	POLR2A	chr6:29604071-29604248	GM12878	blood:	n/a	n/a
36	POLR2A	chr6:29603865-29604289	GM12891	blood:	n/a	n/a
37	POLR2A	chr6:29604192-29604219	GM12878	blood:	n/a	n/a
38	POLR2A	chr6:29604025-29604257	A549	lung:	n/a	n/a
39	POLR2A	chr6:29604073-29604263	HepG2	liver:	n/a	n/a
40	POLR2A	chr6:29604190-29604284	ProgFib	skin:	n/a	n/a
41	POLR2A	chr6:29604115-29604381	HUVEC	blood vessel:	n/a	n/a
42	POLR2A	chr6:29598104-29601707	K562	blood:	n/a	n/a
43	POLR2A	chr6:29604116-29604402	Hela-S3	cervix:	n/a	n/a
44	POLR2A	chr6:29604117-29604421	A549	lung:	n/a	n/a
45	POLR2A	chr6:29599810-29601940	H1-neurons	neurons:	n/a	n/a
46	POLR2A	chr6:29604090-29604406	Gliobla	brain:	n/a	n/a
47	POLR2A	chr6:29604032-29604457	MCF-7	breast:	n/a	n/a
48	POLR2A	chr6:29604069-29604253	GM12891	blood:	n/a	n/a
49	POLR2A	chr6:29603873-29604300	GM12878	blood:	n/a	n/a
50	POLR2A	chr6:29604024-29604251	Hela-S3	cervix:	n/a	n/a

(count:367 , 50 per page) page: 1 2 3 4 5 6 7 8

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr6:29602390-29602440	AoSMC	blood vessel:	n/a
2	chr6:29602390-29602440	AoSMC	blood vessel:	n/a
3	chr6:29602034-29602084	AoSMC	blood vessel:	n/a
4	chr6:29601705-29601755	Caco-2	colon:	n/a
5	chr6:29602390-29602440	Jurkat	blood:	n/a
6	chr6:29602390-29602440	HepG2	liver:	n/a
7	chr6:29601705-29601755	ProgFib	skin:	n/a
8	chr6:29604114-29604164	GM12891	blood:	n/a
9	chr6:29604206-29604256	HNPCEpiC	eye:	n/a
10	chr6:29604114-29604164	MCF-7	breast:	n/a
11	chr6:29604206-29604256	HEEpiC	esophagus:	n/a
12	chr6:29602034-29602084	NHBE	bronchial:	n/a
13	chr6:29604114-29604164	HEK293	kidney:	embryo
14	chr6:29602034-29602084	T-47D	breast:	n/a
15	chr6:29604114-29604164	AG04449	skin:	fetal
16	chr6:29602034-29602084	GM12878	blood:	n/a
17	chr6:29604114-29604164	ovcar-3	ovarian:	n/a
18	chr6:29604148-29604198	T-47D	breast:	n/a
19	chr6:29602034-29602084	Jurkat	blood:	n/a
20	chr6:29604114-29604164	MCF10A-Er-Src	breast:	n/a
21	chr6:29602034-29602084	AG04449	skin:	fetal
22	chr6:29601705-29601755	U87	brain:	n/a
23	chr6:29602390-29602440	GM06990	blood:	n/a
24	chr6:29602034-29602084	HCF	heart:	n/a
25	chr6:29604148-29604198	BJ	skin:	n/a
26	chr6:29602034-29602084	GM06990	blood:	n/a
27	chr6:29602390-29602440	NT2-D1	testis:	n/a
28	chr6:29601705-29601755	Hela-S3	cervix:	n/a
29	chr6:29604114-29604164	HMEC	breast:	n/a
30	chr6:29602034-29602084	HCT-116	colon:	n/a
31	chr6:29602034-29602084	ECC-1	luminal epithelium:	n/a
32	chr6:29604206-29604256	HRCEpiC	kidney:	n/a
33	chr6:29602390-29602440	LNCaP	prostate:	n/a
34	chr6:29602390-29602440	K562	blood:	n/a
35	chr6:29604114-29604164	Jurkat	blood:	n/a
36	chr6:29604206-29604256	Hela-S3	cervix:	n/a
37	chr6:29602390-29602440	SKMC	muscle:	n/a
38	chr6:29602034-29602084	NH-A	brain:	n/a
39	chr6:29604206-29604256	AG09319	gingival:	n/a
40	chr6:29602390-29602440	HUVEC	blood vessel:	n/a
41	chr6:29604148-29604198	AG09319	gingival:	n/a
42	chr6:29604114-29604164	BE2_C	brain:	n/a
43	chr6:29604148-29604198	NH-A	brain:	n/a
44	chr6:29604114-29604164	HL-60	blood:	n/a
45	chr6:29602390-29602440	RPTEC	kidney:	n/a
46	chr6:29604206-29604256	HEK293	kidney:	embryo
47	chr6:29604148-29604198	SK-N-SH	brain:	n/a
48	chr6:29604148-29604198	U87	brain:	n/a
49	chr6:29601705-29601755	NT2-D1	testis:	n/a
50	chr6:29602390-29602440	AG09319	gingival:	n/a

(count:4 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr6:29584985..29587112-chr6:29604597..29606396,2	K562	blood:
2	chr6:29599687..29601377-chr6:29602858..29604767,2	K562	blood:
3	chr6:29598892..29601377-chr6:29602879..29604767,2	K562	blood:
4	chr6:29588373..29590141-chr6:29604757..29606337,2	K562	blood:

(count:1 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-GABBR1-1	chr6:29603837-29604120	NONHSAT108533

No data

Variant related genes	Relation type
SUMO2P1	TF binding region
GABBR1	TF binding region
SUMO2P1	CpG island
GABBR1	CpG island
ENSG00000204681	chromatin interactions

Extended variants
information (count: 112 )
Associated
traits (count: 105 )

Variant overlapped rSNPs/rCNVs (count:112 , 50 per page) page: 1 2 3

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs149164682	chr6:29601697-29601698	Active TSS Flanking Active TSS Enhancers Bivalent/Poised TSS Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
2	rs186826475	chr6:29601727-29601728	Active TSS Flanking Active TSS Enhancers Bivalent/Poised TSS Bivalent Enhancer	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
3	rs372796696	chr6:29601744-29601745	Active TSS Flanking Active TSS Enhancers Bivalent/Poised TSS Bivalent Enhancer	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
4	rs75438822	chr6:29601745-29601746	Active TSS Flanking Active TSS Enhancers Bivalent/Poised TSS Bivalent Enhancer	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
5	rs536879382	chr6:29601746-29601747	Active TSS Flanking Active TSS Enhancers Bivalent/Poised TSS Bivalent Enhancer	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
6	rs191238179	chr6:29601849-29601850	Active TSS Flanking Active TSS Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
7	rs185772718	chr6:29601871-29601872	Active TSS Flanking Active TSS Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
8	rs13220038	chr6:29601895-29601896	Active TSS Flanking Active TSS Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
9	rs558043303	chr6:29601929-29601930	Active TSS Flanking Active TSS Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
10	rs571124402	chr6:29601931-29601932	Active TSS Flanking Active TSS Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
11	rs62392942	chr6:29601938-29601939	Active TSS Flanking Active TSS Enhancers Weak transcription	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
12	rs190242616	chr6:29602021-29602022	Active TSS Flanking Active TSS Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
13	rs62392943	chr6:29602062-29602063	Active TSS Flanking Active TSS Enhancers Weak transcription	CpG island	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
14	rs28359991	chr6:29602067-29602068	Active TSS Flanking Active TSS Enhancers Weak transcription	CpG island	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
15	rs555631741	chr6:29602074-29602075	Active TSS Flanking Active TSS Enhancers Weak transcription	CpG island	1 gene(s)	Overlapped CNVs	n/a
16	rs371264401	chr6:29602077-29602078	Active TSS Flanking Active TSS Enhancers Weak transcription	CpG island	1 gene(s)	Overlapped CNVs	n/a
17	rs541327631	chr6:29602137-29602138	Active TSS Flanking Active TSS Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
18	rs182319359	chr6:29602215-29602216	Active TSS Flanking Active TSS Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
19	rs143292809	chr6:29602251-29602252	Active TSS Flanking Active TSS Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
20	rs548043098	chr6:29602325-29602326	Active TSS Flanking Active TSS Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
21	rs185272787	chr6:29602347-29602348	Active TSS Flanking Active TSS Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
22	rs563713319	chr6:29602390-29602391	Active TSS Flanking Active TSS Enhancers Weak transcription	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
23	rs529403806	chr6:29602399-29602400	Active TSS Flanking Active TSS Enhancers Weak transcription	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
24	rs55971964	chr6:29602442-29602443	Flanking Active TSS Enhancers Weak transcription	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
25	rs188918488	chr6:29602465-29602466	Flanking Active TSS Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
26	rs528306453	chr6:29602467-29602468	Flanking Active TSS Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
27	rs181316987	chr6:29602473-29602474	Flanking Active TSS Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
28	rs571498947	chr6:29602488-29602489	Flanking Active TSS Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
29	rs138928071	chr6:29602522-29602523	Flanking Active TSS Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
30	rs115090429	chr6:29602539-29602540	Flanking Active TSS Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
31	rs566925110	chr6:29602542-29602543	Flanking Active TSS Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
32	rs547512813	chr6:29602706-29602707	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
33	rs199929065	chr6:29602709-29602710	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
34	rs377011078	chr6:29602710-29602711	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
35	rs28749531	chr6:29602717-29602718	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
36	rs185298212	chr6:29602719-29602720	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
37	rs115371741	chr6:29602723-29602724	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
38	rs557279673	chr6:29602734-29602735	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
39	rs541590998	chr6:29602773-29602774	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
40	rs369574988	chr6:29602814-29602815	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
41	rs188250018	chr6:29602849-29602850	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
42	rs116913943	chr6:29602881-29602882	Weak transcription Enhancers Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
43	rs545638509	chr6:29602912-29602913	Weak transcription Enhancers Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
44	rs3130248	chr6:29602936-29602937	Weak transcription Enhancers Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
45	rs527847564	chr6:29602997-29602998	Weak transcription Enhancers Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
46	rs62392944	chr6:29603044-29603045	Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
47	rs542722397	chr6:29603045-29603046	Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
48	rs574024836	chr6:29603136-29603137	Weak transcription Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
49	rs565071279	chr6:29603234-29603235	Weak transcription Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
50	rs528609359	chr6:29603239-29603240	Weak transcription Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:105)

Disease	PMID	Source
Acute lymphoblastic leukemia	22237106	CNVD
Follicular lymphoma	20505157	CNVD
Glioblastoma multiforme	21080181	CNVD
Ewing''s sarcoma	21437220	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Leukemia	21518781	CNVD
Cancer	21637783	CNVD
Facial dysmorphism	22105932	CNVD
Medulloblastoma	21979893	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Diffuse large b-cell lymphoma	18287131	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	19960244	CNVD
Hepatocellular carcinoma	22174799	CNVD
Endometrial cancer	22040021	CNVD
Acute myeloid leukemia	16864856	CNVD
Breast cancer	21264507	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Cancer	16751803	CNVD
Bladder cancer	19088036	CNVD
Wilms tumour	21544195	CNVD
Uveal melanoma	21693616	CNVD
Biliary cancer	19435499	CNVD
Malaria	21533027	CNVD
Retinoblastoma	19183342	CNVD
Acute myeloid leukemia	20729466	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Prostate cancer	18632612	CNVD
Breast cancer	21858162	CNVD
Lung cancer	18438408	CNVD
Ewing''s sarcoma	17952124	CNVD
Gastric cancer	16891809	CNVD
Ovarian cancer	21781307	CNVD
Lung cancer	20668451	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Autism	21448237	CNVD
Cancer	20164919	CNVD
Melanoma	18172304	CNVD
Breast cancer	22844521	CNVD
HIV/AIDS	22844521	CNVD
Ovarian cancer	22844521	CNVD
Prostate cancer	22844521	CNVD
Psoriasis	22844521	CNVD
Rheumatoid arthritis	22844521	CNVD
Sclerosis systemic	22844521	CNVD
Systemic lupus erythematosus	22844521	CNVD
Breast cancer	22522925	CNVD
Breast cancer	21552322	CNVD
Immune disease	21076436	CNVD
Autoimmune disease	19135723	CNVD
Systemic lupus erythematosus	17953491	CNVD
Recurrent Infections	22737222	CNVD
Systemic lupus erythematosus	21904924	CNVD
Ependymoma	19289631	CNVD
Gestational infection	22844521	CNVD
Head circumference	22844521	CNVD
Infertility	22844521	CNVD
Recurrent birth weight diabetes	22844521	CNVD
Obesity	22844521	CNVD
Recurrent pregnancy loss	22844521	CNVD
Intellectual disability	21811512	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Congenital anomalies of the kidney and urinary tract	18694510	CNVD
Nasopharyngeal cancer	22815911	CNVD
Hepatocellular carcinoma	16750200	CNVD
Basal cell lymphoma	21115979	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Breast cancer	17133270	CNVD
Autism	22495311	CNVD
Cancer	16790693	CNVD
Breast cancer	22032731	CNVD
Cervical cancer	21062161	CNVD
Breast cancer	21785460	CNVD
Retinoblastoma	16790693	CNVD
Esophageal adenocarcinoma	18820669	CNVD
Systemic lupus erythematosus	17503323	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
T-cell lymphomas	19863542	CNVD
Urothelial carcinoma	18382360	CNVD
Cancer	21183584	CNVD
Hodgkin''s lymphoma	17606441	CNVD
small cell lung cancer	20016488	CNVD
Renal cell carcinoma	18765545	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Gastric cancer	17908304	CNVD
Myelofibrosis	22110671	CNVD
Breast cancer	16397240	CNVD
Metanephric adenoma	20802469	CNVD
Splenic marginal zone lymphoma	21957467	CNVD
Breast cancer	21364760	CNVD
Schizophrenia	19571809	CNVD
Schizophrenia	19571808	CNVD
Malignant peripheral nerve sheath tumor	18522746	CNVD
Neuroblastoma	16790693	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
abnormal development	18461090	CNVD
Breast cancer	21509527	CNVD
Melanoma	17363583	CNVD
Non-syndromic sensorineural hearing loss	17122850	CNVD

Chromatin state (count:167 , 50 per page) page: 1 2 3 4

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr6:29597600-29602200	Active TSS	iPS-15b Cell Line	embryonic stem cell
2	chr6:29598200-29602000	Active TSS	H9 Cell Line	embryonic stem cell
3	chr6:29599000-29601800	Active TSS	iPS DF 6.9 Cell Line	embryonic stem cell
4	chr6:29599000-29601800	Active TSS	Foreskin Melanocyte Primary Cells skin01	Skin
5	chr6:29599000-29602400	Active TSS	ES-I3 Cell Line	embryonic stem cell
6	chr6:29599200-29601800	Active TSS	HUES6 Cell Line	embryonic stem cell
7	chr6:29599600-29601800	Active TSS	iPS DF 19.11 Cell Line	embryonic stem cell
8	chr6:29599600-29601800	Active TSS	ES-UCSF4 Cell Line	embryonic stem cell
9	chr6:29599600-29601800	Active TSS	Pancreatic Islets	Pancreatic Islet
10	chr6:29599600-29601800	Active TSS	NHLF	lung
11	chr6:29599800-29601800	Active TSS	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
12	chr6:29599800-29601800	Bivalent/Poised TSS	Fetal Intestine Small	intestine
13	chr6:29599800-29602600	Flanking Active TSS	Primary B cells from cord blood	blood
14	chr6:29600000-29601800	Active TSS	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
15	chr6:29600000-29601800	Active TSS	Muscle Satellite Cultured Cells	--
16	chr6:29600000-29601800	Active TSS	Colon Smooth Muscle	Colon
17	chr6:29600000-29601800	Active TSS	Duodenum Smooth Muscle	Duodenum
18	chr6:29600000-29601800	Active TSS	Fetal Kidney	kidney
19	chr6:29600000-29601800	Active TSS	Rectal Smooth Muscle	rectum
20	chr6:29600000-29601800	Active TSS	NHDF-Ad	bronchial
21	chr6:29600000-29602000	Active TSS	HUES64 Cell Line	embryonic stem cell
22	chr6:29600000-29602000	Active TSS	Brain Angular Gyrus	brain
23	chr6:29600000-29602200	Active TSS	Fetal Brain Female	brain
24	chr6:29600200-29601800	Active TSS	Esophagus	oesophagus
25	chr6:29600200-29601800	Bivalent/Poised TSS	Fetal Intestine Large	intestine
26	chr6:29600200-29601800	Active TSS	Rectal Mucosa Donor 29	rectum
27	chr6:29600200-29602000	Active TSS	Stomach Smooth Muscle	stomach
28	chr6:29600400-29601800	Active TSS	Osteobl	bone
29	chr6:29600800-29601800	Flanking Active TSS	Primary Natural Killer cells fromperipheralblood	blood
30	chr6:29601000-29601800	Flanking Active TSS	Primary T cells fromperipheralblood	blood
31	chr6:29601000-29601800	Flanking Active TSS	Primary T helper cells fromperipheralblood	blood
32	chr6:29601000-29601800	Flanking Active TSS	Primary hematopoietic stem cells G-CSF-mobilized Female	--
33	chr6:29601000-29601800	Flanking Active TSS	Adipose Nuclei	Adipose
34	chr6:29601200-29601800	Flanking Active TSS	IMR90 fetal lung fibroblasts Cell Line	lung
35	chr6:29601200-29601800	Bivalent/Poised TSS	Primary hematopoietic stem cells short term culture	blood
36	chr6:29601200-29601800	Flanking Active TSS	Primary T killer naive cells fromperipheralblood	blood
37	chr6:29601200-29601800	Flanking Active TSS	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
38	chr6:29601200-29601800	Flanking Active TSS	Primary hematopoietic stem cells G-CSF-mobilized Male	--
39	chr6:29601200-29601800	Flanking Active TSS	Cortex derived primary cultured neurospheres	brain
40	chr6:29601200-29601800	Flanking Active TSS	Brain Anterior Caudate	brain
41	chr6:29601200-29601800	Flanking Active TSS	K562	blood
42	chr6:29601200-29601800	Flanking Active TSS	NH-A	brain
43	chr6:29601200-29601800	Flanking Active TSS	NHEK	skin
44	chr6:29601200-29602000	Active TSS	ES-WA7 Cell Line	embryonic stem cell
45	chr6:29601200-29602000	Flanking Active TSS	Fetal Brain Male	brain
46	chr6:29601200-29602200	Flanking Active TSS	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
47	chr6:29601200-29602400	Flanking Active TSS	Primary monocytes fromperipheralblood	blood
48	chr6:29601200-29602600	Flanking Active TSS	GM12878-XiMat	blood
49	chr6:29601200-29602800	Flanking Active TSS	Primary B cells from peripheral blood	blood
50	chr6:29601200-29603000	Flanking Active TSS	Monocytes-CD14+_RO01746	blood

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links